Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

NCT05208190 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT05208190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05208190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 4
Overall status
Recruiting
Start date
March 17, 2022
Completion date
December 31, 2028
Enrollment
280 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia